Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control

Version 1 : Received: 22 April 2023 / Approved: 23 April 2023 / Online: 23 April 2023 (13:11:28 CEST)

A peer-reviewed article of this Preprint also exists.

Chand, R.R.; Nimick, M.; Cridge, B.; Rosengren, R.J. Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control. Int. J. Mol. Sci. 2023, 24, 9424. Chand, R.R.; Nimick, M.; Cridge, B.; Rosengren, R.J. Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control. Int. J. Mol. Sci. 2023, 24, 9424.

Abstract

The potential to improve the effectiveness and efficiency of potential estrogen-based oral contraceptives (fertility control) for possums was investigated by comparing the inhibitory potential of hepatic CYP3A and UGT2B catalytic activity using a selected compound library (CYP450 inhibitor-based compounds) in possums to that of three other species (mouse, avian, and human). The results showed higher CYP3A protein levels in possum liver microsomes compared to other test species (up to a 4-fold difference). Also, possum liver microsomes had significantly higher basal p-nitrophenol glucuronidation activity than other test species (up to an 8-fold difference). However, no CYP450 inhibitor-based compounds significantly decreased the catalytic activity of possum CYP3A and UGT2B below the estimated IC50 and 2-fold IC50 values and were therefore not considered to be potent inhibitors of these enzymes. However, compounds such as isosilybin (65%), ketoconazole (72%) and fluconazole (74%) showed reduced UGT2B glucuronidation activity in possums, mainly at 2-fold IC50 values compared to control (p<0.05). Given the structural features of these compounds, these results could provide opportunities for future compound screening. More importantly, however, this study provided preliminary evidence that the basal activity and protein content of two major drug metabolising enzymes differ in possums compared to other test species, suggesting that this could be further exploited to reach the ultimate goal, a potential target-specific fertility control for possums in New Zealand.

Keywords

Brushtail possum; Trichosurus vulpecula; fertility control; and drug-metabolising enzymes (CYP3A and UGT2B)

Subject

Biology and Life Sciences, Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.